Cargando…

Natural Products for the Treatment of Trachoma and Chlamydia trachomatis

The neglected tropical disease (NTD) trachoma is currently the leading cause of eye disease in the world, and the pathogenic bacteria causing this condition, Chlamydia trachomatis, is also the most common sexually transmitted pathogenic bacterium. Although the serovars of this bacterial species typi...

Descripción completa

Detalles Bibliográficos
Autores principales: Potroz, Michael G., Cho, Nam-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272789/
https://www.ncbi.nlm.nih.gov/pubmed/25751782
http://dx.doi.org/10.3390/molecules20034180
_version_ 1783377238615392256
author Potroz, Michael G.
Cho, Nam-Joon
author_facet Potroz, Michael G.
Cho, Nam-Joon
author_sort Potroz, Michael G.
collection PubMed
description The neglected tropical disease (NTD) trachoma is currently the leading cause of eye disease in the world, and the pathogenic bacteria causing this condition, Chlamydia trachomatis, is also the most common sexually transmitted pathogenic bacterium. Although the serovars of this bacterial species typically vary between ocular and genital infections there is a clear connection between genital C. trachomatis infections and the development of trachoma in infants, such that the solutions to these infections are closely related. It is the unique life cycle of the C. trachomatis bacteria which primarily leads to chronic infections and challenges in treatment using conventional antibiotics. This life cycle involves stages of infective elementary bodies (EBs) and reproductive reticulate bodies (RBs). Most antibiotics only target the reproductive RBs and this often leads to the need for prolonged therapy which facilitates the development of drug resistant pathogens. It is through combining several compounds to obtain multiple antimicrobial mechanisms that we are most likely to develop a reliable means to address all these issues. Traditional and ethnobotanical medicine provides valuable resources for the development of novel formulations and treatment regimes based on synergistic and multi-compound therapy. In this review we intend to summarize the existing literature on the application of natural compounds for controlling trachoma and inhibiting chlamydial bacteria and explore the potential for the development of new treatment modalities.
format Online
Article
Text
id pubmed-6272789
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62727892018-12-31 Natural Products for the Treatment of Trachoma and Chlamydia trachomatis Potroz, Michael G. Cho, Nam-Joon Molecules Review The neglected tropical disease (NTD) trachoma is currently the leading cause of eye disease in the world, and the pathogenic bacteria causing this condition, Chlamydia trachomatis, is also the most common sexually transmitted pathogenic bacterium. Although the serovars of this bacterial species typically vary between ocular and genital infections there is a clear connection between genital C. trachomatis infections and the development of trachoma in infants, such that the solutions to these infections are closely related. It is the unique life cycle of the C. trachomatis bacteria which primarily leads to chronic infections and challenges in treatment using conventional antibiotics. This life cycle involves stages of infective elementary bodies (EBs) and reproductive reticulate bodies (RBs). Most antibiotics only target the reproductive RBs and this often leads to the need for prolonged therapy which facilitates the development of drug resistant pathogens. It is through combining several compounds to obtain multiple antimicrobial mechanisms that we are most likely to develop a reliable means to address all these issues. Traditional and ethnobotanical medicine provides valuable resources for the development of novel formulations and treatment regimes based on synergistic and multi-compound therapy. In this review we intend to summarize the existing literature on the application of natural compounds for controlling trachoma and inhibiting chlamydial bacteria and explore the potential for the development of new treatment modalities. MDPI 2015-03-05 /pmc/articles/PMC6272789/ /pubmed/25751782 http://dx.doi.org/10.3390/molecules20034180 Text en © 2015 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Potroz, Michael G.
Cho, Nam-Joon
Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
title Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
title_full Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
title_fullStr Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
title_full_unstemmed Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
title_short Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
title_sort natural products for the treatment of trachoma and chlamydia trachomatis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272789/
https://www.ncbi.nlm.nih.gov/pubmed/25751782
http://dx.doi.org/10.3390/molecules20034180
work_keys_str_mv AT potrozmichaelg naturalproductsforthetreatmentoftrachomaandchlamydiatrachomatis
AT chonamjoon naturalproductsforthetreatmentoftrachomaandchlamydiatrachomatis